1,015
Views
27
CrossRef citations to date
0
Altmetric
Critical Care

Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose

Pages 467-472 | Received 26 Jan 2013, Accepted 22 Apr 2013, Published online: 23 May 2013

References

  • Makin AJ, Wendon J, Williams R. Management of severe cases of paracetamol overdosage. Br J Hosp Med 1994; 52:210–213.
  • Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 2002; 35:876–882.
  • Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2:1097–1100.
  • Clemmesen JO, Ott P, Dalhoff KP, Astrup LB, Tage-Jensen U, Poulsen HE. [Recommendations for treatment of paracetamol poisoning. Danish Medical Society, Study of the Liver]. Ugeskr Læger 1996; 158:6892–6895.
  • Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol 2009; 47:81–88.
  • Schmidt LE, Knudsen TT, Dalhoff K, Bendtsen F. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury. Lancet 2002; 360:1151.
  • Knudsen TT, Thorsen S, Jensen SA, Dalhoff K, Schmidt LE, Becker U, Bendtsen F. Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects. Gut 2005; 54: 515–521.
  • Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous n-acetylcysteine. Ann Emerg Med 1998; 31: 710–715.
  • Bateman DN, Woodhouse KW, Rawlins MD. Adverse reactions to N-acetylcysteine. Hum Toxicol 1984; 3:393–398.
  • Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001; 51:87–91.
  • Lynch RM, Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004; 12:10–15.
  • Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol (Phila) 2008; 46:496–500.
  • Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol 2008; 46:697–702.
  • Merl W, Koutsogiannis Z, Kerr D, Kelly AM. How safe is intravenous N-acetylcysteine for the treatment of paracetamol poisoning?Hong Kong J Emerg Med 2007; 14:198–203.
  • Mant TG, Tempowski JH, Volans GN, Talbot JC. Adverse reactions to acetylcysteine and effects of overdose. BMJ 1984; 289:217–219.
  • Reynard K, Riley A, Walker BE. Respiratory arrest after N- acetylcysteine for paracetamol overdose. Lancet 1992; 340:675.
  • Ho SW, Beilin LJ. Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases. BMJ 1983; 287:876–877.
  • Gheshlagi F, Izadi-Mood N, Amini R, Montazeri G. Prevalence of hypersensitivity reactions to intravenous N-acetylcysteine in acetaminophen poisoned patients. Clin Toxicol 2005; 43:514–515.
  • Sanaei-Zadeh H, Taghaddosinejad F, Jalali N, Kariman H. Adverse effects of intravenous N-acetylcysteine: prospective study on 206 patients with paracetamol poisoning. Clin Drug Invest 2003; 23:129–133.
  • Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37:501–506.
  • Jepsen S, Hansen AB. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest 1994; 54: 543–547.
  • Kerr F, Dawson A, Whyte IM, Buckley N, Murray L, Graudins A, et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005; 45:402–408.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.